Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
USPH Stock Forecast 2026-2027
$65.56
Current Price
$997.74M
Market Cap
Buy 6
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to USPH Price Targets
+52.5%
To High Target of $100.00
+41.9%
To Median Target of $93.00
+34.2%
To Low Target of $88.00
USPH Price Momentum
+3.3%
1 Week Change
+9.0%
1 Month Change
-14.9%
1 Year Change
-16.0%
Year-to-Date Change
-29.9%
From 52W High of $93.50
+12.7%
From 52W Low of $58.19
📊 TOP ANALYST CALLS
Did USPH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if US Physical Therapy is one of their latest high-conviction picks.
Latest USPH Stock Price Targets & Analyst Predictions
Based on our analysis of 5 Wall Street analysts, USPH has a bullish consensus with a median price target of $93.00 (ranging from $88.00 to $100.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $65.56, the median forecast implies a 41.9% upside. This outlook is supported by 6 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
USPH Analyst Ratings
6
Buy
1
Hold
0
Sell
USPH Price Target Range
Low
$88.00
Average
$93.00
High
$100.00
Current: $65.56
Latest USPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for USPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 13, 2026 | Barrington Research | Michael Petusky | Outperform | Maintains | $90.00 |
| May 8, 2026 | Citizens | Constantine Davides | Market Outperform | Maintains | $98.00 |
| Mar 10, 2026 | Jefferies | Brian Tanquilut | Buy | Assumes | $102.00 |
| Feb 20, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Jan 5, 2026 | Barrington Research | Outperform | Maintains | $N/A | |
| Nov 24, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Oct 24, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Sep 18, 2025 | JP Morgan | Benjamin Rossi | Overweight | Assumes | $110.00 |
| Aug 8, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Jul 1, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Apr 22, 2025 | JMP Securities | Market Outperform | Reiterates | $N/A | |
| Mar 19, 2025 | JP Morgan | Overweight | Maintains | $N/A | |
| Feb 28, 2025 | Barrington Research | Outperform | Maintains | $N/A | |
| Dec 16, 2024 | B of A Securities | Buy | Upgrade | $N/A | |
| Dec 16, 2024 | JMP Securities | Market Outperform | Initiates | $N/A | |
| Dec 3, 2024 | JP Morgan | Overweight | Maintains | $N/A | |
| Nov 21, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Nov 7, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Oct 9, 2024 | Barrington Research | Outperform | Maintains | $N/A | |
| Oct 7, 2024 | B of A Securities | Neutral | Downgrade | $N/A |
U.S. Physical Therapy Inc. (USPH) Competitors
The following stocks are similar to US Physical Therapy based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
USPH
US Physical Therapy
mkt cap
965.63M
U.S. Physical Therapy Inc. (USPH) Financial Data
U.S. Physical Therapy Inc. has a market capitalization of $997.74M with a P/E ratio of 131.6x. The company generates $787.68M in trailing twelve-month revenue with a 4.4% profit margin.
Revenue growth is +7.9% quarter-over-quarter, while maintaining an operating margin of +7.3% and return on equity of +6.8%.
Valuation Metrics
Market Cap
$997.74M
Enterprise Value
$1.60B
P/E Ratio
131.6x
PEG Ratio
-1.1x
Price/Sales
1.3x
Growth & Margins
Revenue Growth (YoY)
+7.9%
Gross Margin
+16.5%
Operating Margin
+7.3%
Net Margin
+4.4%
EPS Growth
-49.1%
Financial Health
Cash/Price Ratio
+3.0%
Current Ratio
1.2x
Debt/Equity
46.3x
ROE
+6.8%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
U.S. Physical Therapy Inc. (USPH) Business Model
About U.S. Physical Therapy Inc.
What They Do
Provides outpatient physical therapy services.
Business Model
The company operates a network of outpatient physical therapy clinics, generating revenue by offering rehabilitation services for orthopedic issues, sports injuries, and postoperative conditions. It partners with hospitals, physicians, and employers to deliver customized therapy solutions, enhancing its service offerings and market reach.
Additional Information
U.S. Physical Therapy Inc. is headquartered in Houston, Texas, and plays a vital role in the healthcare sector, addressing the growing demand for physical therapy services due to an aging population and increased awareness of rehabilitation benefits. The company's focus on patient-centered care and evidence-based practices positions it well in the industry.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
4,034
CEO
Mr. Christopher J. Reading
Country
United States
IPO Year
1992
Website
www.usph.comU.S. Physical Therapy Inc. (USPH) Latest News & Analysis
Latest News
Quick Summary
U.S. Physical Therapy, Inc. reported Q1 2026 revenue of $198.3M (+7.9% YoY) but missed EPS expectations due to higher acquisition costs. The company is pursuing hospital partnerships and private insurance strategies.
Why It Matters
Valuation multiples compressing despite revenue growth indicate potential overvaluation concerns. Missed EPS expectations and rising costs may signal financial strain, impacting future stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
U.S. Physical Therapy, Inc. (USPH) CEO Chris Reading presented at the BofA Securities 2026 Healthcare Conference, discussing the healthcare operating environment and the company's key initiatives.
Why It Matters
U.S. Physical Therapy's presentation at a major healthcare conference signals its strategic direction and may influence investor sentiment regarding its growth potential and industry positioning.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
U.S. Physical Therapy, Inc. (USPH) held its Q1 2026 earnings call, discussing financial performance and operational updates. Further details can be found in the full transcript.
Why It Matters
The Q1 2026 earnings call for U.S. Physical Therapy, Inc. provides insights into financial performance and future outlook, impacting stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
1 month ago
Quick Summary
U.S. Physical Therapy, Inc. reported Q1 2026 net revenue of $198.3 million, a 7.9% increase from Q1 2025, with a net income of $5.0 million attributable to shareholders.
Why It Matters
USPH's Q1 2026 revenue growth of 7.9% signals strong operational performance, potentially boosting investor confidence and impacting stock valuations positively.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
U.S. Physical Therapy (USPH) reported Q3 earnings of $0.46 per share, below the Zacks Consensus Estimate of $0.55 and down from $0.48 per share year-over-year.
Why It Matters
USPH's earnings miss signals potential operational challenges, affecting investor confidence and possibly leading to a decline in stock price. Year-over-year decline adds further concern.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
U.S. Physical Therapy (USPH) reported its quarterly financial results for March 2026, highlighting key metrics in relation to Wall Street estimates and previous year figures.
Why It Matters
The comparison of U.S. Physical Therapy's performance metrics to Wall Street estimates and previous years reveals growth potential and financial health, influencing investment decisions.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Frequently Asked Questions About USPH Stock
What is U.S. Physical Therapy Inc.'s (USPH) stock forecast for 2026?
Based on our analysis of 5 Wall Street analysts, U.S. Physical Therapy Inc. (USPH) has a median price target of $93.00. The highest price target is $100.00 and the lowest is $88.00.
Is USPH stock a good investment in 2026?
According to current analyst ratings, USPH has 6 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $65.56. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for USPH stock?
Wall Street analysts predict USPH stock could reach $93.00 in the next 12 months. This represents a 41.9% increase from the current price of $65.56. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is U.S. Physical Therapy Inc.'s business model?
The company operates a network of outpatient physical therapy clinics, generating revenue by offering rehabilitation services for orthopedic issues, sports injuries, and postoperative conditions. It partners with hospitals, physicians, and employers to deliver customized therapy solutions, enhancing its service offerings and market reach.
What is the highest forecasted price for USPH U.S. Physical Therapy Inc.?
The highest price target for USPH is $100.00 from at , which represents a 52.5% increase from the current price of $65.56.
What is the lowest forecasted price for USPH U.S. Physical Therapy Inc.?
The lowest price target for USPH is $88.00 from at , which represents a 34.2% increase from the current price of $65.56.
What is the overall USPH consensus from analysts for U.S. Physical Therapy Inc.?
The overall analyst consensus for USPH is bullish. Out of 5 Wall Street analysts, 6 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $93.00.
How accurate are USPH stock price projections?
Stock price projections, including those for U.S. Physical Therapy Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 13, 2026 4:53 PM UTC